Granules India Q4 Profit Jumps 33% to Rs 201 Crore

Granules India reported a strong finish to FY26, with Granules India Q4 profit rising 33 percent year-on-year to Rs 201 crore.

The company’s performance reflects solid demand, improved margins, and steady execution across key business segments. Revenue for the quarter also climbed to around Rs 1,470 crore, marking a healthy 23 percent increase compared to the same period last year.

The sharp rise in Granules India Q4 profit was driven by higher sales of core products, including widely used drugs like paracetamol and methocarbamol.

The company also benefited from better pricing and cost control, which helped expand margins. Operating performance remained strong, with improved efficiency supporting profitability despite global market pressures.

Also Read: Transforming API & Pharma Manufacturing with Next-Gen EHS Technologies

"We delivered a strong performance in Q4, driven by continued portfolio expansion, disciplined execution, and steady progress across regulatory, compliance, and sustainability initiatives," said Dr. Krishna Prasad Chigurupati, Chairman & Managing Director of Granules India.

For the full financial year, Granules India reported around 20 percent growth in revenue and nearly 19 percent growth in net profit. The numbers highlight the company’s ongoing shift toward more complex and higher-value products, which typically offer better margins than traditional bulk drugs. This strategic move is gradually strengthening its position in global markets, especially in regulated regions like the United States.

Management’s focus on operational discipline and product diversification appears to be paying off, as seen in both quarterly and annual results. The company has been investing in expanding its portfolio and improving manufacturing capabilities, which is helping it stay competitive.

However, future performance will still depend on factors like global demand, pricing trends, and input costs. While the current momentum is strong, maintaining these margins will be key going forward.

Overall, the latest results signal that Granules India is on a steady growth path, backed by improving fundamentals and a clear strategic direction.